Sigilon Therapeutics (SGTX) Announces Strategic Reprioritization to Focus on MPS-1 and Diabetes Dec 13, 2021 05:01PM
Sigilon Therapeutics Announces Strategic Reprioritization Dec 13, 2021 05:00PM